 |
|
Aspirin -- just for men?
October 18, 2007First it was an apple, now it is an aspirin a day that may keep the doctor away. Aspirin has become standard for heart attack prevention, but research published in the online open access journal BMC Medicine suggests that this may really be a man's drug.
Scientists have long puzzled over why the protective effects of aspirin vary so widely between clinical trials. Some trials show no difference between aspirin and placebo, whilst others report that aspirin reduces the risk of a heart attack by more than 50%.
This latest study, from The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, highlights the influence of gender on aspirin's protective powers. Investigators examined the results of 23 previously published clinical trials for the effect for aspirin in heart attack prevention, involving more than 113,000 patients. The authors then analysed how much the ratio of men to women in these trials affected the trials' outcomes.
"Trials that recruited predominantly men demonstrated the largest risk reduction in non-fatal heart attacks," says Dr Don Sin, one of the study's authors. "The trials that contained predominately women failed to demonstrate a significant risk reduction in these non-fatal events. We found that a lot of the variability in these trials seems to be due to the gender ratios, supporting the theory that women may be less responsive to aspirin than men for heart protection."
The mechanisms of this resistance are not yet understood, although recent studies have shown that men and women have major differences in the structure and physiology of the heart's blood vessels.
"From our findings we would caution clinicians on the prescribing aspirin to women, especially for primary prevention of heart attacks," says Dr Sin. "Whether or not other pharmaceutical products would be more effective for women is unclear; more sex-specific studies should now be conducted."
BioMed Central
"Trials that recruited predominantly men demonstrated the largest risk reduction in non-fatal heart attacks," says Dr Don Sin, one of the study's authors. "The trials that contained predominately women failed to demonstrate a significant risk reduction in these non-fatal events. We found that a lot of the variability in these trials seems to be due to the gender ratios, supporting the theory that women may be less responsive to aspirin than men for heart protection."
The mechanisms of this resistance are not yet understood, although recent studies have shown that men and women have major differences in the structure and physiology of the heart's blood vessels.
"From our findings we would caution clinicians on the prescribing aspirin to women, especially for primary prevention of heart attacks," says Dr Sin. "Whether or not other pharmaceutical products would be more effective for women is unclear; more sex-specific studies should now be conducted."
BioMed Central
Aspirin Current Events and Aspirin News RSSLow-dose aspirin does not appear to reduce risk of CV events in patients with diabetes
Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA.
Quintet of proteins forms new, early-warning blood test before heart attack strikes
A team of Johns Hopkins biochemists has identified a mixed bag of five key proteins out of thousands secreted into blood draining from the heart's blood vessels that may together or in certain quantities form the basis of a far more accurate early warning test than currently in use of impending heart attack in people with severely reduced blood flow, or ischemia.
Hospital rankings: More than meets the eye
Medicare's pay-for-performance program ranks and rewards hospitals according to how well they meet certain guidelines for clinical care.
Aspirin does not prevent heart attacks in patients with diabetes
Taking regular aspirin and antioxidant supplements does not prevent heart attacks even in high risk groups with diabetes and asymptomatic arterial disease, and aspirin should only be given to patients with established heart disease, stroke or limb arterial disease.
Triple antiplatelet therapy appears superior to dual antiplatelet therapy
Results of five research studies and a clinical registry first-report presentation scheduled for the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents achieves greater platelet inhibition than conventional dual antiplatelet therapy.
New devices used to reduce arterial occlusions, provide cardiac support, highlighted at TCT 2008
Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Aspirin and atherosclerosis
Aspirin has become one of the most widely used medications in the world, owing to its ability to reduce pain, fevers, inflammation, and blood clotting.
Unusual case of a woman who suffered stroke during sex
Minutes after having sexual intercourse with her boyfriend, a 35-year-old woman suddenly felt her left arm go weak. Her speech became slurred and she lost feeling on the left side of her face.
Common painkillers lower levels of prostate cancer biomarker
Common painkillers like aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer.
Anti-inflammatory drugs may mask prostate cancer marker
Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, may reduce serum levels of the prostate biomarker, PSA (prostate specific antigen), and hence may alter the detection of prostate cancer in individuals who take these medications.
More Aspirin Current Events and Aspirin News Articles
 | How Does Aspirin Find a Headache? (Imponderables Books) by David Feldman Ponder, if you will ... Do snakes sneeze? Why didn't the three musketeers carry muskets? What happens to the holes that are punched out of looseleaf paper? Why don't people smile in old photos? Pop culture guru David Feldman demystifies these questions and much more in How Does Aspirin Find a Headache? Part of the Imponderables® series -- the unchallenged source of answers to civilization's most... |
 | The Aspirin Alternative: The Natural Way to Overcome Chronic Pain by Loes Michael Provides information about the all-natural anti-inflammatory medicine that is the leading non-aspirin drug in Germany... |
 | Aspirin: The Remarkable Story of a Wonder Drug by Diarmuid Jeffreys Diarmuid Jeffreys traces the story of aspirin from the drug’s origins in ancient Egypt, through its industrial development at the end of the nineteenth century and its key role in the great flu pandemic of 1918, to its subsequent exploitation by the pharmaceutical conglomerates and the marvelous powers still being discovered today.... |
| The Aspirin Wars: Money, Medicine and 100 Years of Rampant Competition by Charles C. Mann, Mark L. Plummer Mann and Plummer take us behind the scenes in the aspirin wars to penetrate the shores of capitalism and show the essence of competition at its canniest, most ruthless, most brilliant, and most fierce.ights to Atlantic. 8 pages of... | |
| The Aspirin Age: 1919-1941 by Isabel Leighton A selection of telling essays that bring to life America between the wars. Important social... | |
 | Beyond Aspirin : Nature's Challenge to Arthritis, Cancer & Alzheimer's Disease by Thomas M. Newmark, Paul Schulick Covers: How the COX-2 enzyme creates inflammation in the body; The relationship between COX-2 inflammation and arthritis, specific cancers, and Alzheimer's disease; Herbs and dietary strategies proven to inhibit COX-2 inflammation safely; The dangers of the pharmaceutical 'silver bullet' approach to COX-2 inhibition; Comprehensive scientific support for the herbal strategy; Practical guidelines... |
 | Noni: Aspirin of the Ancients by Diana Fairechild |
| Aspirin Volume 2 (Aspirin) by Eun-jeong Kim | |
 | A Cuppa Tea and an Aspirin by Helen Forrester |
 | Aspirin Volume 1 (Aspirin) by Eun-jeong Kim |
| © 2008 BrightSurf.com |